MD Anderson and German-based Affimed N.V., announced an exclusive strategic clinical development and commercialization collaboration to evaluate Affimed's TandAb technology in combination with MD Anderson's natural killer cell product.
Gradalis Inc. and the Icahn School of Medicine at Mount Sinai established a research alliance to advance the scientific understanding of the Gradalis Vigil Engineered Autologous Tumor Cell therapy.
Phylogica Ltd. said Genentech has extended its exclusivity period for the research collaboration and license agreement to discover novel antibiotics utilizing Phylogica's Phylomer drug discovery platform, including its proprietary cell penetrating peptide discovery technology.
Senhwa Biosciences Inc. of Taipei and San Diego received the orphan drug designation to CX-4945 for the treatment of cholangiocarcinoma.
The American Joint Committee on Cancer has incorporated the Oncotype DX test in its recently published Eighth Edition AJCC Cancer Staging Manual.
Chi Van Dang was appointed scientific director of the Ludwig Institute for Cancer Research.
Jeffrey Vacirca was elected president of the Community Oncology Alliance for a one year term starting Jan. 1.
John Ruckdeschel was named director of the cancer institute of the University of Mississippi Medical Center as well as Ergon Chair in Cancer Research.
Diane Cassels will retire as chief administrator of Winship Cancer Institute of Emory University after 24 years of service, having served in a number roles including including chief department administrator for radiation oncology and administrator for the Emory Clinic's Section of Radiation Oncology and chief operating officer at the Emory Children's Center and Department of Pediatrics.
The American Cancer Society announced the election of three new members of its board of directors:
